am 580 has been researched along with Endometrial Hyperplasia in 1 studies
Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.
Endometrial Hyperplasia: Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanabe, K | 1 |
Utsunomiya, H | 1 |
Tamura, M | 1 |
Niikura, H | 1 |
Takano, T | 1 |
Yoshinaga, K | 1 |
Nagase, S | 1 |
Suzuki, T | 1 |
Ito, K | 1 |
Matsumoto, M | 1 |
Hayashi, S | 1 |
Yaegashi, N | 1 |
1 other study available for am 580 and Endometrial Hyperplasia
Article | Year |
---|---|
Expression of retinoic acid receptors in human endometrial carcinoma.
Topics: Antineoplastic Agents; Benzoates; Carcinoma; Cell Proliferation; Endometrial Hyperplasia; Endometria | 2008 |